We aim to investigate the effects of a single dose of psilocybin, delivered in the context of
pre- and post-dose psychotherapy, on symptoms of depression and burnout suffered by
healthcare clinicians as a result of frontline work in the coronavirus disease of 2019
(COVID) pandemic.